• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于基因编辑的靶向治疗的发展

Development of Targeted Therapies Based on Gene Modification.

作者信息

Benson Taylor M, Leti Fatjon, DiStefano Johanna K

机构信息

Department of Biomedical Research, Center for Genes, Environment, and Health, National Jewish Health, 1400 Jackson Street, Denver, CO, 80206, USA.

Translational Genomics Research Institute, 445 N 5th Street, Phoenix, AZ, 85004, USA.

出版信息

Methods Mol Biol. 2018;1706:39-51. doi: 10.1007/978-1-4939-7471-9_3.

DOI:10.1007/978-1-4939-7471-9_3
PMID:29423792
Abstract

With the advent of next-generation sequencing (NGS) and the demand for a personalized healthcare system, the fields of precision medicine and gene therapy are advancing in new directions. There is a push to identify genes that contribute to disease development, either alone or in conjunction with other genes or environmental factors, and then design targeted therapies based on this knowledge, rather than the traditional approach of treating generalized symptoms with pharmaceuticals in a one-size-fits-all manner. Identification of genes that contribute to disease pathogenesis and progression is critical for the maturation of the precision medicine field. Concomitant with a better understanding of disease pathology, precision medicine approaches can be adopted with greater confidence and are expected to lead to a new standard for clinical practice. In this chapter, we provide a brief introduction to precision medicine, discuss the importance of identifying genes and genetic variants that contribute to disease development and progression, offer examples of approaches that can be applied to treat specific diseases, and present some of the current challenges and limitations of precision medicine.

摘要

随着下一代测序(NGS)技术的出现以及对个性化医疗保健系统的需求,精准医学和基因治疗领域正朝着新的方向发展。人们致力于识别单独或与其他基因或环境因素共同导致疾病发展的基因,然后基于这些知识设计靶向治疗方法,而不是采用传统的一刀切式用药物治疗一般症状的方法。识别导致疾病发病机制和进展的基因对于精准医学领域的成熟至关重要。随着对疾病病理学的更好理解,可以更有信心地采用精准医学方法,并且有望引领临床实践的新标准。在本章中,我们简要介绍精准医学,讨论识别导致疾病发展和进展的基因及基因变异的重要性,提供可用于治疗特定疾病的方法示例,并介绍精准医学当前面临的一些挑战和局限性。

相似文献

1
Development of Targeted Therapies Based on Gene Modification.基于基因编辑的靶向治疗的发展
Methods Mol Biol. 2018;1706:39-51. doi: 10.1007/978-1-4939-7471-9_3.
2
Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.癌症中的下一代测序:精准癌症医学的机遇与挑战
Scand J Clin Lab Invest Suppl. 2016;245:S84-91. doi: 10.1080/00365513.2016.1210331. Epub 2016 Aug 17.
3
Next-Generation sequencing transforming clinical practice and precision medicine.下一代测序技术正在改变临床实践和精准医疗。
Clin Chim Acta. 2023 Nov 1;551:117568. doi: 10.1016/j.cca.2023.117568. Epub 2023 Oct 13.
4
From next-generation sequencing to targeted treatment of non-acquired epilepsies.从下一代测序到非获得性癫痫的靶向治疗。
Expert Rev Mol Diagn. 2019 Mar;19(3):217-228. doi: 10.1080/14737159.2019.1573144. Epub 2019 Feb 4.
5
Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.临床药物基因组学检测在下一代测序时代:精准医学的挑战和机遇。
Expert Rev Mol Diagn. 2018 May;18(5):411-421. doi: 10.1080/14737159.2018.1461561. Epub 2018 Apr 23.
6
Next generation sequencing: implications in personalized medicine and pharmacogenomics.下一代测序:在个性化医疗和药物基因组学中的意义。
Mol Biosyst. 2016 May 24;12(6):1818-30. doi: 10.1039/c6mb00115g.
7
Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.下一代测序(NGS):癌症中药物基因组学和个性化医学的革命性技术。
Adv Exp Med Biol. 2019;1168:9-30. doi: 10.1007/978-3-030-24100-1_2.
8
NGS for Sequence Variants.用于序列变异检测的二代测序技术
Adv Exp Med Biol. 2016;939:1-20. doi: 10.1007/978-981-10-1503-8_1.
9
Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine.精准医学中临床可操作遗传变异的鉴定挑战。
J Healthc Eng. 2016;2016. doi: 10.1155/2016/3617572.
10
NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?对转移性非小细胞肺癌患者进行肿瘤组织和循环游离DNA的二代测序分析以指导基因型导向治疗。是希望还是炒作?
Expert Rev Anticancer Ther. 2017 Aug;17(8):681-685. doi: 10.1080/14737140.2017.1331736. Epub 2017 May 22.